Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 78.00
0.00 (0.00%)
Aug 6, 2026, 1:21 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 6.03 billion as of August 5, 2026. Its market cap has decreased by -52.01% in one year.
Market Cap
6.03B
Enterprise Value
3.52B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
78.00
ChartMarket Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 6.03B, a decrease of -52.11%. That is a compound annual growth rate of -29.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 6.03B | -19.12% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 7.15B |
| ADR Biomedical Holdings | 7.06B |
| MEDINET | 7.04B |
| BrightPath Biotherapeutics | 6.67B |
| CellSource | 6.39B |
| Carna Biosciences | 6.25B |
| Noile-Immune Biotech | 5.90B |
| PRISM BioLab Co.,LTD | 5.80B |